Younger- vs Older-Old Patients with Heart Failure with Preserved Ejection Fraction
- PMID: 31260098
- DOI: 10.1111/jgs.16050
Younger- vs Older-Old Patients with Heart Failure with Preserved Ejection Fraction
Abstract
Objectives: Heart failure with preserved ejection fraction (HFpEF) is now recognized as a geriatric syndrome with multifactorial pathophysiology and clinical heterogeneity rather than a solely left ventricular diastolic dysfunction. Because the pathophysiology of HFpEF is suggested to differ by age, this study compared the clinical characteristics and prognostic factors between HFpEF patients aged 65 to 84 years and those aged 85 years or older.
Design: Retrospective cohort study.
Setting: The Tokyo CCU Network including 73 hospitals in Tokyo, Japan.
Participants: Individuals aged 65 years or older with HFpEF (N = 4305).
Measurements: Very old patients were defined as those aged 85 years or older. Potential risk factors for in-hospital mortality were selected by univariate analyses, and those with a P value <.10 were used in multivariate Cox regression analysis with forward selection (likelihood ratio) to identify significant factors.
Results: Prevalence of hypertension was significantly higher in very old patients, whereas prevalence of coronary artery disease, diabetes mellitus, hyperlipidemia, and smoking was significantly higher in patients aged 65 to 84 years. In very old patients, low systolic blood pressure (hazard ratio [HR] = .988), high serum creatinine level (HR = 1.34), and coexisting chronic obstructive pulmonary disease (COPD; HR = 2.01) were identified as independent risk factors for in-hospital mortality. In contrast, low systolic blood pressure (HR = .987) and low body mass index (HR = .935) were identified as independent risk factors in patients aged 65 to 84 years.
Conclusion: Significant differences were observed in the clinical characteristics and prognostic factors for in-hospital mortality between HFpEF patients aged 65 to 84 and those 85 years and older. Of note, coexisting COPD was associated with significantly lower survival rate only in patients aged 85 years and older, suggesting the prognostic impact of concomitant pulmonary disease in HFpEF may increase with age. These results have implications for future research and management of older HFpEF patients. J Am Geriatr Soc 00:1-6, 2019. J Am Geriatr Soc 67:2123-2128, 2019.
Keywords: aging; chronic obstructive pulmonary disease; geriatrics; heart failure with preserved ejection fraction; very old.
© 2019 The American Geriatrics Society.
Comment in
-
Heart Failure with Preserved Ejection Fraction in Older Adults.J Am Geriatr Soc. 2020 Mar;68(3):664-665. doi: 10.1111/jgs.16304. Epub 2019 Dec 20. J Am Geriatr Soc. 2020. PMID: 31859364 No abstract available.
-
Reply to: Heart Failure With Preserved Ejection Fraction in Older Adults.J Am Geriatr Soc. 2020 Mar;68(3):665-666. doi: 10.1111/jgs.16301. Epub 2019 Dec 20. J Am Geriatr Soc. 2020. PMID: 31859370 No abstract available.
Similar articles
-
Prognostic implications of heart failure with preserved ejection fraction in patients with an exacerbation of chronic obstructive pulmonary disease.Intern Emerg Med. 2016 Jun;11(4):519-27. doi: 10.1007/s11739-015-1319-0. Epub 2015 Sep 30. Intern Emerg Med. 2016. PMID: 26423072
-
Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry.J Cardiol. 2019 Jun;73(6):459-465. doi: 10.1016/j.jjcc.2019.01.005. Epub 2019 Feb 1. J Cardiol. 2019. PMID: 30718015
-
Different prognostic associations of beta-blockers and diuretics in heart failure with preserved ejection fraction with versus without high blood pressure.J Hypertens. 2019 Mar;37(3):643-649. doi: 10.1097/HJH.0000000000001932. J Hypertens. 2019. PMID: 30234786
-
Current perspectives on systemic hypertension in heart failure with preserved ejection fraction.Curr Cardiol Rep. 2014 Dec;16(12):545. doi: 10.1007/s11886-014-0545-9. Curr Cardiol Rep. 2014. PMID: 25326729 Review.
-
Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target.Heart Fail Rev. 2019 Nov;24(6):847-866. doi: 10.1007/s10741-019-09804-2. Heart Fail Rev. 2019. PMID: 31147814 Review.
Cited by
-
Prognostic value of lipid parameters among patients with heart failure: A systematic review and meta-analysis.ESC Heart Fail. 2025 Aug;12(4):2691-2701. doi: 10.1002/ehf2.15315. Epub 2025 May 24. ESC Heart Fail. 2025. PMID: 40411472 Free PMC article.
-
Prognostic effect of a vasopressin V2 receptor antagonist in acute congestive heart failure patients with hypoperfusion, the wet-cold pattern.Eur J Clin Pharmacol. 2024 Nov;80(11):1795-1805. doi: 10.1007/s00228-024-03745-y. Epub 2024 Aug 21. Eur J Clin Pharmacol. 2024. PMID: 39168874
-
Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction.ESC Heart Fail. 2025 Apr;12(2):799-808. doi: 10.1002/ehf2.14958. Epub 2024 Jul 12. ESC Heart Fail. 2025. PMID: 38993173 Free PMC article.
-
Different Impact of Beta-Blockers on Long-Term Mortality in Heart Failure Patients with and without Chronic Obstructive Pulmonary Disease.J Clin Med. 2021 Sep 25;10(19):4378. doi: 10.3390/jcm10194378. J Clin Med. 2021. PMID: 34640396 Free PMC article.
-
Association of ambient temperature and acute heart failure with preserved and reduced ejection fraction.ESC Heart Fail. 2022 Oct;9(5):2899-2908. doi: 10.1002/ehf2.14010. Epub 2022 Jun 19. ESC Heart Fail. 2022. PMID: 35719026 Free PMC article.
References
REFERENCES
-
- Upadhya B, Pisani B, Kitzman DW. Evolution of a geriatric syndrome: pathophysiology and treatment of heart failure with preserved ejection fraction. J Am Geriatr Soc. 2017;65:2431-2440.
-
- Juilliere Y, Venner C, Filippetti L, Popovic B, Huttin O, Selton-Suty C. Heart failure with preserved ejection fraction: a systemic disease linked to multiple comorbidities, targeting new therapeutic options. Arch Cardiovasc Dis. 2018;111:766-781.
-
- Upadhya B, Taffet GE, Cheng CP, Kitzman DW. Heart failure with preserved ejection fraction in the elderly: scope of the problem. J Mol Cell Cardiol. 2015;83:73-87.
-
- Loffredo FS, Steinhauser ML, Jay SM, et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 2013;153:828-839.
-
- Burkhoff D, Maurer MS, Packer M. Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? Circulation. 2003;107:656-658.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical